Drugs / Glucose-Insulin-Potassium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02591927 Comparator | Feb 2016 → Feb 2019 | myocardial infarction | Centre Hospitalier Universitaire Vaudois | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glucose-Insulin-Potassium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02591927 ↗ |
| Route | Intravenous | “continuous I.V. infusion” NCT02591927 ↗ |